---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-018296"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T08:37:39.922175+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Phibro Animal Health reports Q1 net loss of $8.0M; lowers FY2024 guidance

## Summary
- Net sales $231.3M (-1% YoY); net loss $8.0M vs $3.9M net income prior year; diluted loss per share $0.20.
- Adjusted EBITDA $18.7M (-16% YoY); adjusted diluted EPS $0.14 (-33%).
- Animal Health segment sales up 4% to $160.5M; Mineral Nutrition down 6%; Performance Products down 18%.
- FY2024 guidance reduced: net sales $980M-$1.02B, adjusted EBITDA $106M-$112M, adjusted diluted EPS $1.04-$1.16.
- Results include $10.4M pension settlement charge, $6.7M FX losses; Israel conflict causing manufacturing disruptions.

## SEC filing metadata
- accession: 0001558370-23-018296
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000155837023018296/0001558370-23-018296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000155837023018296/pahc-20231108x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-018296
- JSON: https://secwatch.observer/filing/0001558370-23-018296.json
- Plain text: https://secwatch.observer/filing/0001558370-23-018296.txt

## Key facts
- Earnings Releases
  PHIBRO ANIMAL HEALTH CORP reported the fiscal quarter ended September 30, 2023 results: revenue $231.3 million, net income Net loss of $8.0 million, EPS Diluted loss per share of $0.20. Guidance reaffirmed.
  - Period: the fiscal quarter ended September 30, 2023
  - Revenue: $231.3 million
  - Net income: Net loss of $8.0 million
  - EPS: Diluted loss per share of $0.20
  - Guidance: reaffirmed
  - Result: reported results
  source text: guidance for the year ending June 30, 2024. ​ Highlights for the three months ended September 30, 2023 (compared to the three months ended September 30, 2022) ​ - Net sales of $231.3 million, a decrease of $1.2 million, or 1% - Net loss of $8.0 million, a decrease of $11.9 million - Diluted loss per share of $0.20, a decrease of $0.30 - Adjusted EBITDA of $18.7
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000155837023018296/0001558370-23-018296-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.